期刊论文详细信息
ClinicoEconomics and Outcomes Research | |
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain | |
关键词: baricitinib; cost-effectiveness; JAK inhibitor; rheumatoid arthritis; | |
DOI : | |
来源: DOAJ |
【 授权许可】
Unknown